SMI 998089 / CH0009980894
12’370.57
Pkt
-12.90
Pkt
-0.10 %
05.09.2025
| Kurse + Charts + Realtime | Nachrichten | Listen | Info | zugeh. Wertpapiere | |
|---|---|---|---|---|---|
| Snapshot | Chart (gross) | Marktberichte | enthaltene Werte | GV-Termine | Strukturierte Produkte |
| Historisch | Chartvergleich | Analysen | Top/Flop | Dividenden | Trading-Depot |
| Realtime Liste | Realtime Chart (Indikation) | Marktkapitalisierung | |||
Kurse + Charts + Realtime
Nachrichten
Info
zugeh. Wertpapiere
Analysen zu SMI-Werten
| 11.02.25 | ABB Underperform | Bernstein Research | |
| 11.02.25 | UBS Buy | Deutsche Bank AG | |
| 11.02.25 | Richemont Buy | UBS AG | |
| 11.02.25 | UBS Outperform | RBC Capital Markets | |
| 11.02.25 | ABB Neutral | Goldman Sachs Group Inc. | |
| 10.02.25 | Roche Sell | Goldman Sachs Group Inc. | |
| 10.02.25 | Roche Outperform | Bernstein Research | |
| 07.02.25 | UBS Halten | DZ BANK | |
| 07.02.25 | ABB Kaufen | DZ BANK | |
| 07.02.25 | UBS Overweight | JP Morgan Chase & Co. | |
| 06.02.25 | Nestlé Neutral | UBS AG | |
| 06.02.25 | Novartis Neutral | Goldman Sachs Group Inc. | |
| 06.02.25 | Roche Sell | Goldman Sachs Group Inc. | |
| 06.02.25 | UBS Buy | Goldman Sachs Group Inc. | |
| 05.02.25 | Zurich Insurance Hold | Deutsche Bank AG | |
| 05.02.25 | Nestlé Market-Perform | Bernstein Research | |
| 04.02.25 | Roche Sell | Deutsche Bank AG | |
| 04.02.25 | UBS Buy | Goldman Sachs Group Inc. | |
| 04.02.25 | UBS Hold | Deutsche Bank AG | |
| 04.02.25 | UBS Overweight | JP Morgan Chase & Co. | |
| 04.02.25 | Novartis Buy | Deutsche Bank AG | |
| 04.02.25 | UBS Outperform | RBC Capital Markets | |
| 04.02.25 | UBS Buy | Goldman Sachs Group Inc. | |
| 03.02.25 | Roche Underweight | JP Morgan Chase & Co. | |
| 03.02.25 | Novartis Hold | Deutsche Bank AG | |
| 03.02.25 | Novartis Kaufen | DZ BANK | |
| 03.02.25 | Nestlé Neutral | UBS AG | |
| 03.02.25 | Novartis Buy | UBS AG | |
| 31.01.25 | Roche Sell | Deutsche Bank AG | |
| 31.01.25 | Novartis Neutral | Goldman Sachs Group Inc. | |
| 31.01.25 | Novartis Buy | UBS AG | |
| 31.01.25 | ABB Sell | Deutsche Bank AG | |
| 31.01.25 | Roche Neutral | UBS AG | |
| 31.01.25 | UBS Overweight | JP Morgan Chase & Co. | |
| 31.01.25 | Novartis Outperform | Bernstein Research | |
| 31.01.25 | Novartis Hold | Jefferies & Company Inc. | |
| 31.01.25 | ABB Neutral | UBS AG | |
| 30.01.25 | Roche Outperform | Bernstein Research | |
| 30.01.25 | ABB Underperform | Bernstein Research | |
| 30.01.25 | Roche Underweight | JP Morgan Chase & Co. |